Clik here to view.
逆转人体软骨老化、恢复活力；日本江户川医院取得史无前例的成就
东京 (美国商业资讯)–因年龄相关的磨损或损伤或骨关节炎而严重受损时，膝关节的软骨需在关节置换手术中被摘除，并且通常会被丢弃，而现在它们或可恢复活力。衰老相关ß半乳糖苷酶、p16和p21标记证实，通过一种逆转衰老的颠覆性技术，这类软骨有望成为细胞治疗的潜在细胞来源。上述结果发表于《自然》(Nature)下属期刊《科学报告》(Scientific Reports,...
View ArticleClik here to view.
ヒト軟骨細胞の老化を逆転、若さを取り戻す 初の偉業に江戸川病院（東京）が成功
東京 （ビジネスワイヤ） — 加齢による摩耗、怪我、変形性関節症等で損傷した膝関節の軟骨は、関節置換手術の際に取り除かれ廃棄されています。しかし、この軟骨が、細胞の老化を逆転させる画期的な技術（老化関連の β- ガラクトシダーゼ、p16、p21マーカーにより確認）によって若返り、細胞治療に利用できるという論文がNature誌のScientific Reports...
View ArticleClik here to view.
Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel...
TOKYO & HAIFA, Israel Minovia Therapeutics, Ltd. (CEO; Natalie Yivgi-Ohana, Ph.D., “Minovia”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today...
View ArticleClik here to view.
Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of...
DEERFIELD, Ill. Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100...
View ArticleClik here to view.
Athersys and Healios K.K. Announce Advancement of Their MultiStem Commercial...
CLEVELAND & TOKYO Athersys, Inc. (NASDAQ: ATHX) and HEALIOS K.K. (Healios) (TSE Mothers: 4593) jointly announced today an expansion and deepening of their partnership to optimize and better...
View ArticleClik here to view.
Daniela Drago Joins Aurion Biotech as Chief Regulatory Officer
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced it has...
View ArticleClik here to view.
EdiGene Announces Clinical Sites Activation and First Patient Enrolled in...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc. (“Company”, or “EdiGene”), today announced the first patient enrolled in multicenter Phase I clinical study of its investigational gene-editing...
View ArticleClik here to view.
RxCell Inc., A*STAR’s IMCB, NUS, and SERI Collaborate to Develop Cellular...
SAN FRANCISCO RxCell, a Bay Area-based biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC), together with the Agency for Science, Technology and...
View ArticleClik here to view.
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel...
NEW YORK & HONG KONG Treadwell Therapeutics today announced the acquisition of TCRyption Inc., a company focusing on novel approaches to TCR based T cell therapy and a TIO Bioventures portfolio...
View ArticleClik here to view.
School of Life Sciences and Technology, Indonesia Wins XVI Fujio Cup Quiz in...
TOKYO Alfred Patisenah and Daisy Ramadhani of School of Life Sciences and Technology, Indonesia, won the prestigious Fujio Cup Quiz (FCQ), an active knowledge gaining academic event of NCRM NICHE...
View ArticleClik here to view.
Aurion Biotech Announces Medical Advisory Board
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced the...
View ArticleClik here to view.
Treadwell Therapeutics宣布收购专注于新型TCR-T细胞疗法的TIO Bioventures投资组合公司TCRyption Inc.
纽约和香港 (美国商业资讯)–Treadwell Therapeutics今天宣布收购TCRyption Inc.，后者专注于新型TCR-T细胞疗法，是TIO...
View ArticleClik here to view.
印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛；印度Rajalakshmi工程学院获得亚军
东京 (美国商业资讯)–来自印尼生命科学与技术学院(School of Life Sciences and Technology, Indonesia)的Alfred Patisenah和Daisy Ramadhani在著名的Fujio Cup Quiz (FCQ)比赛中获胜。FCQ是2021年日印再生医学中心NICHE大会(NCRM NICHE...
View ArticleClik here to view.
横河電機 革新的なバイオプロセス向けデジタルツイン技術をもつInsilico Biotechnologyを買収
東京 （ビジネスワイヤ） — 横河電機株式会社（本社：東京都武蔵野市 代表取締役社長：奈良 寿）は、バイオプロセス分野向けにソフトウェアの開発、およびサービスを提供しているInsilico Biotechnology AG（インシリコ バイオテクノロジー AG 本社：ドイツ シュトゥットガルト CEO：Klaus Mauch 以下...
View ArticleClik here to view.
Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess...
TOKYO Yokogawa Electric Corporation (TOKYO:6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess...
View ArticleClik here to view.
横河电机收购创新型生物过程数字孪生技术开发商Insilico Biotechnology
东京 (美国商业资讯)–横河电机株式会社(Yokogawa Electric Corporation, TOKYO:6841)宣布已收购Insilico Biotechnology AG...
View ArticleClik here to view.
Business Partnership for Development and Commercialization of Medical Device...
TOKYO & MOUNTAIN VIEW, Calif. SanBio Company Limited (hereafter, “the Company”) hereby announces that it entered into a business partnership agreement with D&P Bioinnovations, Inc. (San...
View ArticleClik here to view.
PeptiGrowth Inc. Is Launching A Novel Synthetic Peptide TGFβ1 Inhibitor,...
TOKYO PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jiro Sugimoto) has successfully developed a novel peptide called TGFβ1 inhibitor (TGFβ1 binding peptide) which binds to TGFβ1 to...
View ArticleClik here to view.
横河電機 1細胞解析に革命をもたらす細胞内サンプリングシステム「SS2000」を開発
東京 （ビジネスワイヤ） — 横河電機株式会社（本社：東京都武蔵野市 代表取締役社長：奈良 寿）は、培養中の細胞を共焦点顕微鏡で高精細に撮像し、特定の細胞や1細胞内成分のサンプリング工程を自動で正確に実行する Single Cellome™ System （シングル・セローム・システム）「...
View ArticleClik here to view.
Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling
TOKYO Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed the Single Cellome™ System SS2000, a single-cell analysis solution that utilizes high-resolution images captured with...
View Article